KİLCİ, F. Et Al. 2022. Ectopic parathyroid hormone as a rare aetiology of hypercalcemia with rhabdomyosarcoma: a new treatment strategy with Zoledronic Acid and Denosumab. JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM , vol.35, no.8 , 1107-1112.

KİLCİ, F., DEMİRSOY, U., JONES, J. H., ÇAKIR, Ö., & ÇİZMECİOĞLU JONES, F. M., (2022). Ectopic parathyroid hormone as a rare aetiology of hypercalcemia with rhabdomyosarcoma: a new treatment strategy with Zoledronic Acid and Denosumab. JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM , vol.35, no.8, 1107-1112.

KİLCİ, FATİH Et Al. "Ectopic parathyroid hormone as a rare aetiology of hypercalcemia with rhabdomyosarcoma: a new treatment strategy with Zoledronic Acid and Denosumab," JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM , vol.35, no.8, 1107-1112, 2022

KİLCİ, FATİH Et Al. "Ectopic parathyroid hormone as a rare aetiology of hypercalcemia with rhabdomyosarcoma: a new treatment strategy with Zoledronic Acid and Denosumab." JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM , vol.35, no.8, pp.1107-1112, 2022

KİLCİ, F. Et Al. (2022) . "Ectopic parathyroid hormone as a rare aetiology of hypercalcemia with rhabdomyosarcoma: a new treatment strategy with Zoledronic Acid and Denosumab." JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM , vol.35, no.8, pp.1107-1112.

@article{article, author={FATİH KİLCİ Et Al. }, title={Ectopic parathyroid hormone as a rare aetiology of hypercalcemia with rhabdomyosarcoma: a new treatment strategy with Zoledronic Acid and Denosumab}, journal={JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM}, year=2022, pages={1107-1112} }